Literature DB >> 6161880

Cell participation in immune response by immune ribonucleic acid. I. The role of T lymphocytes in immune response by immune RNA against T-dependent antigens.

K Saito, T Natsuno, S Mitsuhashi.   

Abstract

T- and B-cell participation in the immune response induced by immune ribonucleic acid (iRNA) preparations against T-dependent antigens was studied using athymic nude, neonatally thymectomized (NT) and cyclophosphamide-treated (CY) mice. The iRNA(T + B) preparations were made from the spleen of BALB/c mice immunized with these antigens. Injection of the iRNA into nude or NT mice caused an increase in the number of specific rosette-forming cells (RFC) and of memory cells capable of responding to secondary stimulus with a small dose of the corresponding antigen. Injection with T-dependent antigens or with iRNA(T + B) did not cause any immune response in CY mice, suggesting depletion of the B-cell function. The iRNA(T) and iRNA(B) were prepared, respectively, from the thymuses of BALB/c mice and from the spleens of nude mice which had been immunized with T-dependent antigens. Injection of nude mice with both iRNA(T) and iRNA(B) caused an increase in the number of specific RFC and the secondary antibody formation response after boosting with a small dose of the corresponding antigen. Injection of iRNA(T) preparation into nude mice could induce the anamnestic response after boosting. However, neither of the iRNA(T) or iRNA(B) preparation could induce in nude mice the proliferation of the number of specific RFC. These results indicate the presence of at least two kinds of iRNA preparations against T-dependent antigens and that the cooperation of iRNA(T) and iRNA(B) was required for the induction of immune response against T-dependent antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161880      PMCID: PMC1458302     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  Dose effect of immune ribonucleic acid fraction on antibody formation.

Authors:  K Kitamura; S Kurashige; S Mitsuhashi
Journal:  Jpn J Microbiol       Date:  1973-01

2.  The role of RNA in cell-mediated immunity.

Authors:  S Mitsuhashi; K Saito; S Kurashige; N Osawa; K Kitamura
Journal:  Ann N Y Acad Sci       Date:  1973-05-31       Impact factor: 5.691

3.  Antibody formation against Salmonella flagella by an immune ribonucleic acid fraction.

Authors:  N Yamaguchi; S Kurashige; S Mitsuhashi
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

4.  Transfer agent of immunity. VI. Serial passive transfers of cellular immunity to Salmonella infection ribonucleic acid.

Authors:  K Saito; N Osawa; S Mitsuhashi
Journal:  Jpn J Microbiol       Date:  1971-03

5.  Transfer agent of immunity. IV. Antibody formation against diphtheria toxin by an immune ribonucleic acid fraction.

Authors:  S Kurashige; K Kitamura; K Akama; S Mitsuhashi
Journal:  Jpn J Microbiol       Date:  1970-01

6.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

7.  Studies on the immune response to fixed antigens. Preferential induction of helper function with heavily trinitrophenylated sheep erythrocytes, and glutaraldehyde-treated sheep erythrocytes.

Authors:  M Kahan; R Berman-Goldman; R Saltoun; D Naor
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

8.  Expermental salmonellosis. XI. Induction of cellular immunity and formation of antibody by transfer agent of mouse mononuclear phagocytes.

Authors:  S Mitsuhashi; K Saito; N Osawa; S Kurashige
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

  8 in total
  1 in total

1.  Cell preparation in immune response by immune ribonucleic acid. II. Independence of T lymphocytes in immune response against T-independent antigens.

Authors:  K Saito; T Natsuno; S Mitsuhashi
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.